Molecular Partners AG (XSWX:MOLN)
CHF 3.395 -0.115 (-3.36%) Market Cap: 111.59 Mil Enterprise Value: -59.19 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 53/100

Molecular Partners AG - Special Call Transcript

Dec 12, 2019 / 01:00PM GMT
Release Date Price: CHF17.78 (+4.59%)
Seth Lewis
Molecular Partners AG - SVP of IR, Communications & Strategy

(technical difficulty)

perhaps in Europe listening on the webcast. My name is Seth Lewis. I recently joined Molecular Partners as Senior Vice President, Investor Relations Communications, based here in the U.S. Very excited to welcome you all here today to share with you the Molecular Partners update. This program themed Novel Therapeutic Designs Applied. Very exciting panel of speakers, both internally and externally, quite a packed presentation set up this morning.

As you'll be aware, we are a public company, and we will be making various forward-looking statements. I'll refer you to our disclosures. Just want to turn to the agenda and kick things off. As you'll see, as I mentioned, both combination of folks from our internal team, both from the CEO and from our Chief Medical Officer and our Discovery team, but then also from our external experts who have been kind enough to join us, who will speak across our portfolio.

One of the things that I hope you'll get today is some of the excitement that I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot